Moderna said it would seek emergency use authorisation for its Covid-19 vaccine for children under the age of six in the US and EU in coming weeks after interim results from its clinical trial showed the jab is safe and produces a positive immune response.
莫德纳(Moderna)表示，该公司将在未来几周为其新冠疫苗用于美国和欧盟的6岁以下儿童寻求紧急使用授权。此前其临床试验的中期结果显示，疫苗注射是安全的，并能诱导出积极的免疫反应。
您已阅读8%（346字），剩余92%（3894字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。